MiR-221 Promotes Hepatocellular Carcinoma Cells Migration via Targeting PHF2

Table 1

Correlation between the HCC patients’ clinicopathologic characteristics and miR‐211 expression.

	miR-221 expression
Variables	n = 36		P
Age
≤57 years	13	2.63±0.54	0.340
>57 years	23	2.85±0.50
Gender
Male	26	2.64±0.75	0.415
Female	10	2.48±0.33
Tumor size
≤7cm	20	2.33±0.37	0.001
>7cm	16	3.31±0.23
pT status
p	21	2.68±0.52	0.161
p	15	2.98±0.59
pN status
p	12	2.37±0.40	0.001
pN2-pN3	24	3.28±0.21
TNM stage
II	18	2.34±0.37	0.001
III-IV	18	3.28±0.24
Serum AFP
≤400μg/L	11	2.40±0.47	0.014
>400μg/L	25	2.55±0.47
Microvascular invasion
Yes	10	2.81±0.62	0.268
No	26	3.09±0.61
Portal vein tumor thrombus
Yes	9	2.87±0.30	0.323
No	27	3.14±0.43